Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 30.84%4.71B | 7.05%16.19B | 2.66%11.37B | --7.56B | --3.6B | 8.32%15.13B | 8.49%11.08B | 15.36%13.96B | --10.21B | --12.11B |
| Operating income | 30.84%4.71B | 7.05%16.19B | 2.66%11.37B | 7.56B | 3.6B | 8.32%15.13B | 8.49%11.08B | 15.36%13.96B | 10.21B | 12.11B |
| Cost of sales | ---- | ---- | ---- | ---6.06B | ---- | ---- | ---- | -13.23%-10.81B | ---8B | ---9.55B |
| Operating expenses | -28.00%-3.53B | -9.41%-12.69B | -5.70%-9.06B | -6.06B | -2.76B | -7.35%-11.6B | -7.05%-8.57B | -13.23%-10.81B | -8B | -9.55B |
| Gross profit | 40.18%1.18B | -0.75%3.5B | -7.76%2.31B | 1.5B | 839.58M | 11.62%3.52B | 13.72%2.51B | 23.30%3.16B | 2.21B | 2.56B |
| Selling expenses | -17.66%-285M | 2.08%-965.73M | 2.80%-670.42M | ---441.03M | ---242.23M | -6.53%-986.21M | -10.56%-689.73M | -6.04%-925.75M | ---623.85M | ---873M |
| Administrative expenses | -2.59%-102.56M | 17.56%-415.93M | 12.56%-320.17M | ---234.61M | ---99.97M | -18.21%-504.51M | -34.44%-366.14M | -13.67%-426.79M | ---272.35M | ---375.47M |
| Research and development expenses | -7.45%-20.52M | 5.29%-92.07M | 9.29%-64.7M | ---39.93M | ---19.1M | -2.90%-97.21M | -5.77%-71.33M | -1.22%-94.47M | ---67.44M | ---93.33M |
| Profit from asset sales | 3,439.87%330.68K | 58.11%-1.46M | 64.14%-1.1M | ---- | ---9.9K | ---3.47M | ---3.07M | ---- | ---- | ---- |
| Revaluation surplus | -8.66%9.35M | -87.11%8.02M | -76.72%1.92M | ---- | --10.24M | --62.23M | --8.24M | ---- | ---- | ---- |
| -Changes in the fair value of other assets | -8.66%9.35M | -87.11%8.02M | -76.72%1.92M | ---- | --10.24M | --62.23M | --8.24M | ---- | ---- | ---- |
| Impairment and provision | -561.16%-20.9M | -264.29%-216.87M | -147.20%-32.51M | ---11.7M | ---3.16M | -1,448.98%-59.53M | -748.44%-13.15M | 138.52%4.41M | --2.03M | ---11.46M |
| -Other impairment is provision | -561.16%-20.9M | -264.29%-216.87M | -147.20%-32.51M | ---11.7M | ---3.16M | -1,448.98%-59.53M | -748.44%-13.15M | 138.52%4.41M | --2.03M | ---11.46M |
| Special items of operating profit | 2.83%28.16M | 49.24%112.93M | 58.50%74.01M | --112.03M | --27.39M | -67.30%75.67M | -78.22%46.69M | -0.22%231.41M | --214.37M | --231.92M |
| Operating profit | 53.83%743.83M | -4.47%1.8B | -8.38%1.21B | 889.3M | 483.56M | -3.23%1.88B | -9.39%1.32B | 35.21%1.95B | 1.46B | 1.44B |
| Financing income | 245.83%24.14M | -22.67%57.13M | -47.96%34.18M | ---- | --6.98M | --73.87M | --65.68M | ---- | ---- | ---- |
| Financing cost | -123.33%-4.56M | -1,032.74%-17.45M | -147.00%-18.18M | ---5.4M | ---2.04M | 89.16%-1.54M | 27.82%-7.36M | -14.86%-14.22M | ---10.2M | ---12.38M |
| Share of profits of associates | ---- | ---- | ---- | --2.42M | ---- | ---- | ---- | 111,400.00%4.45M | --2.9M | ---4K |
| Special items of earning before tax | -47.91%16.23M | 5.59%35.76M | 189.46%33.56M | ---- | --31.16M | --33.87M | --11.59M | ---- | ---- | ---- |
| Earning before tax | 43.60%746.01M | -7.79%1.83B | -10.22%1.25B | 886.32M | 519.51M | 2.69%1.99B | -4.20%1.39B | 35.70%1.94B | 1.45B | 1.43B |
| Tax | ---- | ---- | ---- | ---211.26M | ---- | ---- | ---- | -40.65%-435.05M | ---310.32M | ---309.31M |
| After-tax profit from continuing operations | 44.22%567.4M | -9.52%1.37B | -10.51%950.38M | 675.06M | 393.43M | 0.83%1.51B | -6.87%1.06B | 34.33%1.5B | 1.14B | 1.12B |
| Earning after tax | 44.22%567.4M | -9.52%1.37B | -10.51%950.38M | 675.06M | 393.43M | 0.83%1.51B | -6.87%1.06B | 34.33%1.5B | 1.14B | 1.12B |
| Minority profit | 485.96%4.24M | -64.27%10.29M | -92.23%1.16M | ---882K | ---1.1M | 24.66%28.79M | -19.79%14.94M | 40.18%23.09M | --18.62M | --16.47M |
| Profit attributable to shareholders | 42.74%563.16M | -8.46%1.36B | -9.35%949.22M | 675.94M | 394.52M | 0.46%1.48B | -6.65%1.05B | 34.24%1.48B | 1.12B | 1.1B |
| Basic earnings per share | 25.93%1.7 | -13.39%4.4 | -12.01%3.15 | 2.31 | 1.35 | 0.79%5.08 | -6.53%3.58 | 29.56%5.04 | 3.83 | 3.89 |
| Diluted earnings per share | 25.93%1.7 | -13.39%4.4 | -12.01%3.15 | 2.31 | 1.35 | 0.79%5.08 | -6.28%3.58 | 30.23%5.04 | 3.82 | 3.87 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | IAS | CAS (2007) | CAS (2007) | CAS (2007) | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.